Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling

LEUKEMIA(2017)

引用 8|浏览46
暂无评分
摘要
Leukemia accepted article preview online, 03 October 2017. doi:10.1038/leu.2017.305.
更多
查看译文
关键词
Cancer microenvironment,Myelodysplastic syndrome,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要